Jenburkt Pharmaceuticals accepted the resignation of Vinay Bhatt, Senior Vice President of International Business, effective September 18, 2026. The departure follows discussions regarding operational and strategic matters.

Bhatt cited personal reasons for his exit after serving the company for 21 years. His resignation was filed under Regulation 30(4) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.

Key Details

• Resignation effective date: September 18, 2026
• Reason: Personal reasons
• Tenure: 21 years with the organization
• Role: Senior Vice President, International Business

The company stated that ensuring business continuity remains a priority. Bhatt suggested a one-on-one discussion to finalize the handover process and notice period timeline.

Jenburkt Pharmaceuticals shareholders approved all resolutions at its 41st Annual General Meeting on September 4, 2026, with near-unanimous support. The vote included the re-appointment of Dilip H. Bhuta as CFO for five years.

The company declared a dividend of ₹20.70 per share (207%) for FY26. Voting results were submitted to the BSE under Regulation 44(3) of the SEBI LODR Regulations, 2015. M/s. Nilesh Shah & Associates served as the scrutinizer.

Voting Results

A total of 7,332 shareholders were on record. While no shareholders attended physically, 51 participants joined via Video Conferencing. The promoter group held 2,057,450 shares and cast 1,916,350 votes in favor across key resolutions, representing 93.14% participation from their holdings.

Public non-institutional shareholders held 23,54,217 shares but polled only 9,795 votes (0.42%). Institutional public shareholders did not vote. Two votes were cast against the financial statements and dividend resolutions.

Governance and Compliance

The statutory and secretarial auditor reports contained no adverse qualifications. Independent Director Krishnan Subharaman was absent due to travel. The Chairman addressed 46 shareholder questions regarding financial results, product innovations, and market presence.

Leadership Continuity

Dilip H. Bhuta, aged 74, continues as Whole Time Director and CFO until March 31, 2032. He has served the company since July 2013. Remuneration is approved for the initial three-year period ending March 31, 2030. Bhuta brings 42 years of banking experience, having retired as Managing Director of BOB Cards Ltd in January 2012.

What the Numbers Show

The 207% dividend yield underscores strong cash generation relative to share capital. Combined with a debt-free balance sheet, this indicates a capital allocation strategy focused on returning value to shareholders rather than aggressive reinvestment.